{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:01:33Z","timestamp":1787986893918,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejogrb.2020.09.016","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:44:30Z","timestamp":1600083870000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Evolution of serum Anti-M\u00fcllerian Hormone (AMH) level in young women treated with chemotherapy for breast cancer according to basal AMH level"],"prefix":"10.1016","volume":"254","author":[{"given":"S.","family":"Loubersac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dezellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6440-2928","authenticated-orcid":false,"given":"T.","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-7579","authenticated-orcid":false,"given":"A.","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Barriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-7709","authenticated-orcid":false,"given":"T.","family":"Freour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejogrb.2020.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","article-title":"Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study","volume":"18","author":"Fidler","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0010","first-page":"72","article-title":"Prospective evaluation of serum anti-M\u00fcllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer","volume":"79","author":"Dezellus","year":"2017","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0015","author":"Anderson","year":"2017","journal-title":"European Journal of Cancer"},{"issue":"March","key":"10.1016\/j.ejogrb.2020.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.008","article-title":"Anti-m\u00fcllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy","volume":"74","author":"Fr\u00e9our","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of Taxanes, endocrine therapy, and deleterious germline BRCA mutations on anti-m\u00fcllerian hormone levels in early breast cancer patients treated with anthracycline- and cyclophosphamide-based chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front Oncol"},{"issue":"September (9)","key":"10.1016\/j.ejogrb.2020.09.016_bib0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10815-017-0977-4","article-title":"Potential therapeutic applications of human anti-M\u00fcllerian hormone (AMH) analogues in reproductive medicine","volume":"34","author":"Kushnir","year":"2017","journal-title":"J Assist Reprod Genet"},{"issue":"February (9)","key":"10.1016\/j.ejogrb.2020.09.016_bib0035","first-page":"E1688","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci."},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0040","author":"Dewailly","year":"2011","journal-title":"Human Reproduction"},{"issue":"July (7)","key":"10.1016\/j.ejogrb.2020.09.016_bib0045","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"issue":"July (7)","key":"10.1016\/j.ejogrb.2020.09.016_bib0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-m\u00fcllerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2020.09.016_bib0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2013.10.007","article-title":"AMH concentration is not related to effective time to pregnancy in women who conceive naturally","volume":"28","author":"Streuli","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"November (11)","key":"10.1016\/j.ejogrb.2020.09.016_bib0060","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2015-2474","article-title":"Is anti-m\u00fcllerian hormone associated with fecundability? Findings from the EAGeR trial","volume":"100","author":"Zarek","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.ejogrb.2020.09.016_bib0065","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.09.016_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0075","author":"Amir","year":"2010","journal-title":"The Breast"},{"issue":"May (1)","key":"10.1016\/j.ejogrb.2020.09.016_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-014-2914-x","article-title":"What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis","volume":"145","author":"Zhao","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"August (9588)","key":"10.1016\/j.ejogrb.2020.09.016_bib0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.ejogrb.2020.09.016_bib0090","first-page":"403","article-title":"Polycystic ovarian syndrome (PCOS), related symptoms\/sequelae, and breast cancer risk in a population-based case\u2013control study","volume":"27","author":"Kim","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"October (8)","key":"10.1016\/j.ejogrb.2020.09.016_bib0095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast Cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.09.016_bib0100","author":"Barry Human Reproduction","year":"2014","journal-title":"Update"},{"issue":"January (1)","key":"10.1016\/j.ejogrb.2020.09.016_bib0105","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"March(3)","key":"10.1016\/j.ejogrb.2020.09.016_bib0110","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-m\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"September","key":"10.1016\/j.ejogrb.2020.09.016_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.07.001","article-title":"Fertility and pregnancy issues in BRCA-mutated breast cancer patients","volume":"59","author":"Lambertini","year":"2017","journal-title":"Cancer Treat Rev"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520305923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520305923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:49:42Z","timestamp":1759556982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520305923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"alternative-id":["S0301211520305923"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.09.016","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of serum Anti-M\u00fcllerian Hormone (AMH) level in young women treated with chemotherapy for breast cancer according to basal AMH level","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}